CXCL9 and malaria: Seven studies investigated the effect of IPTp-SP [11–17], whereas the remaining four investigated adverse pregnancy outcomes associated with submicroscopic placental malaria [18, 19], infection with P. falciparum and measures of placental malaria [4] and CXCL9 response to malaria during pregnancy [20].